Bioventix (LON:BVXP) Stock Passes Below Two Hundred Day Moving Average – Here’s What Happened

Bioventix PLC (LON:BVXP – Get Free Report)’s share price passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 1,763.27 and traded as low as GBX 1,600. Bioventix shares last traded at GBX 1,665, with a volume of 12,235 shares.

Bioventix Stock Performance

The company has a market cap of £87.78 million, a price-to-earnings ratio of 11.96 and a beta of 0.56. The firm has a fifty day moving average price of GBX 1,636.07 and a 200 day moving average price of GBX 1,762.69.

Get Bioventix alerts:

Bioventix (LON:BVXP – Get Free Report) last issued its earnings results on Monday, March 30th. The biotechnology company reported GBX 69.38 earnings per share for the quarter. Bioventix had a net margin of 59.30% and a return on equity of 65.83%. The business had revenue of GBX 615.88 billion for the quarter. On average, analysts expect that Bioventix PLC will post 166.3066955 EPS for the current fiscal year.

Insider Transactions at Bioventix

In other news, insider Peter John Harrison bought 1,065 shares of the business’s stock in a transaction that occurred on Wednesday, April 8th. The stock was acquired at an average cost of GBX 1,849 per share, for a total transaction of £19,691.85. Also, insider Bruce Hiscock bought 66 shares of the business’s stock in a transaction that occurred on Monday, April 27th. The stock was purchased at an average price of GBX 1,679 per share, with a total value of £1,108.14. Insiders have bought 2,131 shares of company stock worth $3,927,999 in the last ninety days. Insiders own 6.16% of the company’s stock.

Bioventix Company Profile

(Get Free Report)

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.

Recommended Stories

• Five stocks we like better than Bioventix
• Workday Validates AI Flywheel: Stock Price Recovery Begins
• HubSpot at 2019 Levels Is an Opportunity—Not a Warning
• Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus?
• Kiniksa Pharmaceuticals Still Has Room to Run After 100% Rally

Receive News & Ratings for Bioventix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioventix and related companies with MarketBeat.com's FREE daily email newsletter.